Proposed Criteria for Classification of Acute Myeloid Leukemia in Dogs and Cats

Veterinary Clinical Pathology

Volumn 20, Issue 3, 1991, Pages 63-82

  Jain, Neml C ^a   Blue, Julia T ^b   Grindem, Carol B ^c   Harvey, John W ^d   Koclba, Gary J ^e   Krehbiel, Janver D ^f   Latimer, Kenneth S ^g   Raskin, Rose E ^d   Thrall, Mary A ^h   Zinkl, Joseph G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^f MICHIGAN STATE UNIVERSITY   (United States)

^g UNIVERSITY OF GEORGIA   (United States)

^h Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002483484     PISSN: 02756382     EISSN: 1939165X     Source Type: Journal    
DOI: 10.1111/j.1939-165X.1991.tb00571.x     Document Type: Article

References (107)

1. Dysmyelopoiesis in the Cat: A Hematological Disorder Resembling Refractory Anemla With Excess Blasts in Man
2. Non‐Lymphoid Hematopoietic Neoplasia in Cats: A Retrospective Study of 60 Cases
3. Megakaryoblastic Leukemia in a Dog
4. Platelet Dysplasia Associated With Megakaryoblastic Leukemia in a Dog
5. Bilateral Trigeminal Nerve Paralysis and Horner's Syndrome Associated With Myelomonocytic Neoplasia in a Dog
6. Acute Myelomonocytic Leukemia With Neurologic Manifestations in the Dog
7. Cytogenetic Analysis of Leukaemic Cells in the Dog. A Report of 10 Cases and a Review of the Literature
8. Cytogenetic Analysis in Nine Leukaemic Cats
9. Morphologic Classification and Clinical and Pathologic Characteristics of Spontaneous Leukemia in 17 Dogs
10. Cytochemical Reactions in Cells from Leukemic Cats
11. Cytochemical Reactions in Cells from Leukemic Dogs
12. Canine and Feline Lymphoid and Myeloid Tumors Encountered in Tokyo
13. Acute Nonlymphocytic Leukemia in a Dog
14. Myeloproliferative Disorders in Dogs and Cats
15. Clinico‐Pathological Findings and Cytochemical Characterization of Myelomonocytic Leukemia in 5 Dogs
16. Acute Monocytic Leukemia in a Dog
17. Basophilic Leukemia in a Dog
18. Identification and Characterization of Megakaryoblasts in Acute Megakaryoblastic Leukemia in a Dog
19. Tumors of the Lymphoid and Hematopoietic Tissues
20. Myelodysplastic Changes in a Cat With Myelomonocytic Leukemia
21. Megakaryoblastic Leukemia in a Dog
22. Acute Myelomonocytic Leukemla in a Horse
23. Histopathological and Hematological Findings in Myeloid Leukemia induced by a New Feline Leukemia Virus isolate
24. Myeloproliferative Disorders
25. Idarubicin in Acute Leukemia: An Effective New Therapy for the Future
26. A New Regimen of Amsacrine With High‐dose Cytarabine is Safe and Effective Therapy for Acute Leukemia
27. Acute Toxicity and First Clinical Results of lntensive Postinduction Therapy Using a Modified Busulfan and Cyclophosphamide Regimen With Autologous Bone Marrow Rescue in First Remission of Acute Myeloid Leukemia
28. Differentiation in Acute Myeloid Leukemia and Myelodysplastic Disorders. Is Differentiation‐Induction Therapy Possible?
29. Update on Therapeutic Options for Chronic Myelogenous Leukemia
30. Acute Nonlymphocytic Leukemia in Adults: Pathophysiology, Status of Current Therapy, and New Approaches
31. The Impact of Colony Stimulating Factors on Cancer Chemotherapy
32. Proposals for the Classification of the Acute Leukemias. French‐American‐British (FAB) Cooperative Group
33. Classification of Acute Leukaemias
34. A Variant Form of Hypergranular Promyelocytic Leukemia (M3)
35. Proposal for the Classification of the Myelodysplastic Syndromes
36. Criteria for the Diagnosis of Acute Leukemia of Megakaryocyte Lineage (M7)
37. Proposed Revised Criteria for the Classification of Acute Myeloid Leukemia
38. Peripheral Acute Leukemia: High Peripheral But Low‐Marrow Blast Count
39. Report of the National Cancer Institute‐Sponsored Workshop on Definitions of Diagnosis and Response in Acute Myeloid Leukemia
40. Clinical and Laboratory Data Related to Maturation in Acute Leukemia
41. Maturation Index: A Contribution to Quantification in the FAB Classification of Acute Leukemia
42. Modifications in the Classification of Primary Myelodysplastic Syndromes: The Addition of a Scoring System
43. Proposals for the Classification of Chronic (Mature) B and T Lymphoid Leukaemias. French‐American‐British (FAB) Cooperative Group
44. The Morphological Classification of Acute Lymphocytic Leukemia: Concordance Among Observers and Clinical Correlations
45. Monocytic Leukemia in infancy. A Review of Eight Cases
46. Diagnostic Concurrence in the Subclassification of Adult Acute Leukemia Using French‐American‐British Criteria
47. Myelodysplastic Syndromes: Analysis of 131 Cases According to the FAB Classification
48. Prognostic Factors of Myelodysplastic Syndromes ‐ A Simplified 3‐D Scoring System
49. The Myelodysplastic Syndrome ‐ A Practical Guide
50. Institutional Performance in Application of the FAB Classification of Acute Leukemia. The Southwest Oncology Group Experience
51. Chronic Myelomonocytic Leukemia: Clinical Features, Cytogenetics, and Prognosis in 30 Consecutive Cases
52. Analysis of the Presenting Features of Adult Acute Leukemia: The French‐American‐British Classification
53. Acute Lomonocytic Leukemia With Abnormal Eoslnophlls and Inv(16) or T(16;16) Has a Favorable Prognosis
54. Association of an Inversion of Chromosome 16 With Abnormal Marrow Eosinophils in Acute Myelomonocytic Leukemia
55. Acute Nonlymphoblastic Leukemia. Prognostic Factors in Adults With Long‐term Follow‐up
56. Distribution of 250 Cases of Acute Myeloid Leukemia (AML) According to the FAB Classification and Response to Therapy
57. Report of the Committee on Structural Chromosome Changes in Neoplasia
58. Chemotherapy for Acute Myelogenous Leukemia in Children and Adults: VAPA Update
59. Prognostic Value of Cytologic Parameters in Acute Myelogenous Leukemia
60. Characterizing ‘Difficult’ Acute Leukemias. A Combined Electron Microscopic and immunological Marker Study
61. Morphometrical Evaluation of Acute Leukemic Cells by Electron Microscopy. Discrepancy Between Morphological Characteristics in FAB Classification and Electron Microscopic Morphometry
62. Ultrastructural Features in 100 Cases of Acute Myeloid Leukemia
63. Immunophenotype of Leukemic Blasts With Small Peroxidase‐Positive Granules Detected by Electron Microscopy
64. Immunological and Cytochemical Characterization of Megakaryocytic Lineage Leukemia
65. Simultaneous Detection of Membrane Markers With Monocional Antibodies and Peroxidatic Activities in Leukemia: Ultrastructural Analysis Using a New Method of Fixation Preserving the Platelet Peroxidase
66. Detection of Cells of Megakaryocyte Lineage in Haematological Alignancies by Immuno‐Alkaline Phosphatase Labelling Cell Smears With a Panel of Monocional Antibodies
67. Acute Leukemia of Adults. Ultrastructural, Cytochemical, and Histological Observations in 100 Cases
68. Minimally Differentiated Acute Nonlymphocytic Leukemia: A Distinct Entity
69. Determination of Ultrastructural Peroxidases and Immunologic Membrane Markers in the Diagnosis of Acute Leukemias
70. Relevance of Ultrastructural Immunocytochemistry in the Characterization of Unclassifiable Leukemias: Correlation With Phenotypic and Genic Studies
71. Acute Myeloid Leukemia: Correlation Between FAB Classification Criteria and Surface Antigenic Markers
72. Immunophenotyping of Acute Myeloid Leukemia by Immune‐Alkaline Phosphatase (APAAP) Labeling With a Panel of Antibodies
73. Use of Surface Marker Analysis to Predict Outcome of Adult Acute Myeloblastic Leukemia
74. Immunophenotyping in the Classification of Acute Leukemia in Adults. Interpretation of Multiple Lineage Reactivity
75. Heterogenelty in Acute Undifferentiated Leukemia
76. Classifying Acute Leukemia by Immunophenotyping: A Combined FAB‐Immunologic
77. Immunophenotype of Blast Cells in Acute Myeloid Leukemia May Be a Useful Predictive Factor for Outcome
78. Monoclonal Antibodies Against Myeloperoxidase are Valuable Immunological Reagents for the Diagnosis of Acute Myeloid Leukemia
79. Chronic Myelogenous Leukemia ‐ Past, Present, and Future
80. The Contribution of Cytochemistry and Immunophenotyping to the Reproducibility of the FAB Classification in Acute Leukemia
81. Proposal for the Recognition of Minimally Differentiated Acute Myeloid Leukemia (AML‐MO)
82. Basophils in Acute Myeloid Leukemia
83. Studies on the Histogenesis of Blood Platelets
84. Experimental Immunologic Thrombocytopenia in Dogs: A Study of Thrombocytopenia and Megakaryocytopolesis
85. Probable Essential Thrombocythemia in a Dog
86. Morphologic Classification, Response to Therapy, and Survival in 263 Adult Patients With Acute Nonlymphoblastic Leukemia
87. Subclassification of Acute Lymphoblastic Leukemia in Children: Analysis of the Reproducibility of Morphological Criteria and Prognostic Implications
88. Leukemia Classification: A Study of the Accuracy of Diagnosis in 456 Patients
89. Acute Nonlymphocytic Leukemias of Childhood. Inter‐Observer Variability and Problems in the Use of the FAB Classification
90. The Revised French‐American‐British Classification of Acute Myeloid Leukemia: Is New Better?
91. Morphologic, Immunologic and Cytogenetic Studies in Erythroleukemia: Evidence for Multilineage Involvement and Identification of Two Distinct Cytogenetic‐Clinicopathologic Types
92. Origin of Granules in Polymorphonuclear Leukocytes: Two Types Derived From Opposite Faces of the Golgi Complex in Developing Granulocytes
93. Cytochemistry of Esterases
94. Cytochemical Characterization of Leukemic Cells From 20 Dogs
95. Cytochemical Characterization of Feline Leukemic Cells
96. Cytochemistry of Canine and Feline Leukocytes and Leukemias
97. Nonspecific Esterase Cytochemistry in Acute Myeloblastic Leukemia: Alpha‐Naphthyl Acetate Versus Alpha‐Naphthyl Butyrate
98. Auer Rods in the Acute Myeloid Leukemias: Frequency and Methods of Demonstration
99. Hematologic Abnormalities Preceding Myeloid Leukemia in Three Cats
100. Nonspecific Esterase of Acute Myelomonocytic Leukemia (M3)
101. Serum Lysozyme (Muraminidase) Activity in Dogs With Neoplastic Disease
102. Phenotyping of Canine Lymphoma with Monoclonal Antibodies Directed at Cell Surface Antigens: Classification, Morphology, Clinical Presentation and Response to Chemotherapy
103. Monoclonal Antibodies. Clinical Uses and Potential